IL122942A0 - Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them - Google Patents

Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them

Info

Publication number
IL122942A0
IL122942A0 IL12294296A IL12294296A IL122942A0 IL 122942 A0 IL122942 A0 IL 122942A0 IL 12294296 A IL12294296 A IL 12294296A IL 12294296 A IL12294296 A IL 12294296A IL 122942 A0 IL122942 A0 IL 122942A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
arabinofuranosylcytosine
beta
esters
compositions containing
Prior art date
Application number
IL12294296A
Other languages
English (en)
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of IL122942A0 publication Critical patent/IL122942A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Artificial Filaments (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
IL12294296A 1995-07-25 1996-07-12 Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them IL122942A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515279.9A GB9515279D0 (en) 1995-07-25 1995-07-25 Improved therapeutic agents
PCT/NO1996/000179 WO1997005154A1 (en) 1995-07-25 1996-07-12 Improved therapeutic agents

Publications (1)

Publication Number Publication Date
IL122942A0 true IL122942A0 (en) 1999-05-09

Family

ID=10778247

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12294296A IL122942A0 (en) 1995-07-25 1996-07-12 Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them
IL122942A IL122942A (en) 1995-07-25 1998-01-15 Pharmaceutical preparations containing esters of D – ß – 1 - arabinopuranosyl cytosine and some new esters of this type

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL122942A IL122942A (en) 1995-07-25 1998-01-15 Pharmaceutical preparations containing esters of D – ß – 1 - arabinopuranosyl cytosine and some new esters of this type

Country Status (25)

Country Link
US (2) US6316425B1 (de)
EP (1) EP0842185B1 (de)
JP (2) JP4372227B2 (de)
KR (1) KR100401909B1 (de)
AT (1) ATE207076T1 (de)
AU (1) AU714814B2 (de)
CA (1) CA2227533C (de)
CZ (1) CZ291612B6 (de)
DE (1) DE69616074T2 (de)
DK (1) DK0842185T3 (de)
ES (1) ES2166900T3 (de)
GB (1) GB9515279D0 (de)
HU (1) HU224839B1 (de)
IL (2) IL122942A0 (de)
MX (1) MX9800622A (de)
NO (1) NO313985B1 (de)
NZ (1) NZ313790A (de)
PL (1) PL183601B1 (de)
PT (1) PT842185E (de)
RU (1) RU2165260C2 (de)
SK (1) SK283003B6 (de)
TW (1) TW434251B (de)
UA (1) UA55389C2 (de)
WO (1) WO1997005154A1 (de)
ZA (1) ZA966047B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
WO1998021223A1 (en) * 1996-11-12 1998-05-22 Medivir Ab Nucleosides
DE69812934T2 (de) * 1997-01-24 2004-01-29 Conpharma As Oslo Gemcitabin-derivate
US7393862B2 (en) * 2002-05-17 2008-07-01 Celgene Corporation Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
WO2005049633A1 (en) * 2003-11-03 2005-06-02 Cognis Ip Management Gmbh Acyl ribonucleosides and acyl deoxyribonucleosides
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US8497292B2 (en) * 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
EP2205073A4 (de) * 2007-09-26 2013-03-06 Sinai School Medicine Azacytidin-analoge und ihre verwendungen
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
CN102740833A (zh) * 2009-11-20 2012-10-17 克拉维斯制药公司 吉西他滨衍生物的肠胃外制剂
US8912162B2 (en) 2010-07-13 2014-12-16 Clavis Pharma Asa Parenteral formulations of elacytarabine derivatives
AU2013241341B2 (en) * 2012-03-28 2016-09-08 Fujifilm Corporation Salt of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine
US12059427B2 (en) 2018-01-15 2024-08-13 Yinuoke Medicine Science And Technology Company Ltd. Treatments for cachexia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894000A (en) * 1971-01-27 1975-07-08 Upjohn Co Ara-cytidine derivatives and process of preparation
RU2085557C1 (ru) 1991-09-30 1997-07-27 Санкио Компани Лимитед Производные нуклеозидов пиримидина или их фармацевтически приемлемые соли и способ их получения
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
US5641758A (en) 1993-11-10 1997-06-24 Kluge; Michael Cytarabine derivatives, the preparation and use thereof

Also Published As

Publication number Publication date
EP0842185B1 (de) 2001-10-17
AU6633596A (en) 1997-02-26
WO1997005154A1 (en) 1997-02-13
US6335322B1 (en) 2002-01-01
PL183601B1 (pl) 2002-06-28
GB9515279D0 (en) 1995-09-20
RU2165260C2 (ru) 2001-04-20
CA2227533C (en) 2007-01-09
UA55389C2 (uk) 2003-04-15
TW434251B (en) 2001-05-16
NO980296D0 (no) 1998-01-23
KR100401909B1 (ko) 2004-02-14
ATE207076T1 (de) 2001-11-15
HUP9900924A2 (hu) 2001-05-28
CZ16398A3 (cs) 1998-06-17
CZ291612B6 (cs) 2003-04-16
JP2009215326A (ja) 2009-09-24
IL122942A (en) 2006-12-10
DK0842185T3 (da) 2002-02-04
HUP9900924A3 (en) 2001-06-28
ES2166900T3 (es) 2002-05-01
CA2227533A1 (en) 1997-02-13
HU224839B1 (en) 2006-03-28
SK283003B6 (sk) 2003-01-09
PT842185E (pt) 2002-04-29
KR19990035804A (ko) 1999-05-25
ZA966047B (en) 1997-02-04
PL324690A1 (en) 1998-06-08
MX9800622A (es) 1998-11-30
EP0842185A1 (de) 1998-05-20
NO980296L (no) 1998-01-23
DE69616074T2 (de) 2002-06-06
JP5087052B2 (ja) 2012-11-28
SK8098A3 (en) 1998-07-08
DE69616074D1 (de) 2001-11-22
JP4372227B2 (ja) 2009-11-25
NZ313790A (en) 1999-07-29
NO313985B1 (no) 2003-01-13
US6316425B1 (en) 2001-11-13
JP2002504068A (ja) 2002-02-05
AU714814B2 (en) 2000-01-13

Similar Documents

Publication Publication Date Title
AU5278096A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
PL324430A1 (en) Novel inhibitors of pharnesiltransferase, their production and pharmaceutic compositions containing them
PL321710A1 (en) Novel inhibitors of farnseferase, their production and pharmaceutic compositions containing them
AU1180997A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
AU5476396A (en) Pharmaceutical compositions containing irbesartan
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
EP0811595A4 (de) Hydrochalconderivate, diese enthaltende kosmetische zubereitungen, und verfahren zur herstellung derselben
HUP9701690A3 (en) Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU7727196A (en) Oxygen generating compositions
HUP9801356A3 (en) Triciclic (2-hydroxy-2-methyl-3,3,3-trifluoropropanoyl)-amino-benzoxepine, -benzothiepine, -benzocycloheptene, -indene derivatives and pharmaceutical compositions containing them
WO1996021468A3 (en) Chemically modified interferon
IL122942A0 (en) Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
GR3033591T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
AU5402896A (en) New taxoids, their preparation and pharmaceutical compositions containing same
HK1014137A1 (en) Benzopyrans and pharmaceutical compositions containing them
IL99233A0 (en) Phosphonopyrrolidine-and phosphonopiperidine-containing pseudopeptides of the statin type,their preparation and pharmaceutical compositions containing them
IL106290A0 (en) Enzyme inhibitors,their preparation and pharmaceutical compositions containing them
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
PL325170A1 (en) Bipolar forms of throwaflocacin
AU5994796A (en) Modified kojibiosides analogues
AU1180897A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HU9700437D0 (en) Substituted thiophenyl-alkenyl-carboxylic-acid-guanidid-derivatives, their production, their use as active component of pharmaceutical compositions, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
ERR Corrigendum

Free format text: IN JOURNAL 9/2006 P. 3455 PATENT APPLICATION NO. 122942 GB 25.7.1995 WO 1997/05154 CORRECT PRIORITYCLAIM CORRECT INTERNATIONAL PUBLICATION NO. TO JULY 24, 2007

FF Patent granted
KB Patent renewed